© 1996 by Oxford University Press
Journal of the National Cancer Institute, Vol. 88, No. 21, 1571-1579,
November 6, 1996
© 1996 Oxford University Press
Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality Rates
Special Population Studies Branch, Division of Cancer Prevention and Control
Applied Research Branch, Division of Cancer Prevention and Control
Cancer Statistics Branch, Division of Cancer Prevention and Control
Cancer Control Research Program, Division of Cancer Prevention and Control
Biostatistics Branch, Division of Epidemiology and Genetics, National Cancer Institute Bethesda, MD
Kenneth C. Chu, Ph.D., National Institutes of Health, EPN 240, Bethesda, MD 20892.
Background: Clinical trials have demonstrated that use of mammographic screening and advances in therapy can improve prognosis for women with breast cancer. Purpose: We determined the trends in breast cancer mortality rates, as well as incidence and survival rates by extent of disease at diagnosis, for white women in the United States and considered whether these trends are consistent with widespread use of such beneficial medical interventions. Methods: We examined mortality data from the National Center for Health Statistics and incidence and survival data by extent of disease from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute, all stratified by patient age, using statistical-regression techniques to determine changes in the slope of trends over time. Results: The age-adjusted breast cancer mortality rate for U.S. white females dropped 6.8% from 1989 through 1993. A significant decrease in the slope of the mortality trend of approximately 2% per year was observed in every decade of age from 40 to 79 years of age. Trends in incidence rates were also similar among these age groups: localized disease rates increased rapidly from 1982 through 1987 and stabilized or increased more slowly thereafter; regional disease rates decreased after 1987; and distant disease rates have remained level over the past 20 years. Three-year relative survival rates increased steadily and significantly for both localized and regional disease from 1980 through 1989 in all ages, with no evidence of an increase in slope in the late 1980s. Implications: The decrease in the diagnosis of regional disease in the late 1980s in women over the age of 40 years likely reflects the increased use of mammography earlier in the 1980s. The increase in survival rates, particularly for regional disease, likely reflects improvements in systemic adjuvant therapy. Statistical modeling indicates that the recent drop in breast cancer mortality is too rapid to be explained only by the increased use of mammography; likewise, there has been no equivalent dramatic increase in survival rates that would implicate therapy alone. Thus, indications are that both are involved in the recent rapid decline in breast cancer mortality rates in the United States. [J Natl Cancer Inst 1996;88:1571–9]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Krieger Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections Int. J. Epidemiol., June 1, 2008; 37(3): 627 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Kahn Moving Research From Bench to Bedside to Community: There Is Still More to Do J. Clin. Oncol., February 1, 2008; 26(4): 523 - 526. [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Albano, E. Ward, A. Jemal, R. Anderson, V. E. Cokkinides, T. Murray, J. Henley, J. Liff, and M. J. Thun Cancer Mortality in the United States by Education Level and Race J Natl Cancer Inst, September 19, 2007; 99(18): 1384 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Anderson, A. S. Reiner, R. K. Matsuno, and R. M. Pfeiffer Shifting Breast Cancer Trends in the United States J. Clin. Oncol., September 1, 2007; 25(25): 3923 - 3929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Cronin-Fenton, L. A. Ries, L. X. Clegg, and B. K. Edwards Rising Incidence Rates of Breast Carcinoma With Micrometastatic Lymph Node Involvement J Natl Cancer Inst, July 4, 2007; 99(13): 1044 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Smith-Bindman, D. L. Miglioretti, N. Lurie, L. Abraham, R. B. Barbash, J. Strzelczyk, M. Dignan, W. E. Barlow, C. M. Beasley, and K. Kerlikowske Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med, April 18, 2006; 144(8): 541 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mercatali, V. Valenti, D. Calistri, S. Calpona, G. Rosti, S. Folli, M. Gaudio, G. L. Frassineti, D. Amadori, and E. Flamini RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients Ann. Onc., March 1, 2006; 17(3): 424 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Jatoi, W. F. Anderson, S. R. Rao, and S. S. Devesa Breast Cancer Trends Among Black and White Women in the United States J. Clin. Oncol., November 1, 2005; 23(31): 7836 - 7841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Hance, W. F. Anderson, S. S. Devesa, H. A. Young, and P. H. Levine Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute J Natl Cancer Inst, July 6, 2005; 97(13): 966 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E.-H. Fuleihan, M. Salamoun, Y. A. Mourad, A. Chehal, Z. Salem, Z. Mahfoud, and A. Shamseddine Pamidronate in the Prevention of Chemotherapy-Induced Bone Loss in Premenopausal Women with Breast Cancer: A Randomized Controlled Trial J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3209 - 3214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D Althuis, J. M Dozier, W. F Anderson, S. S Devesa, and L. A Brinton Global trends in breast cancer incidence and mortality 1973-1997 Int. J. Epidemiol., April 1, 2005; 34(2): 405 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Radina and J. M. Armer Surviving Breast Cancer and Living with Lymphedema: Resiliency among Women in the Context of Their Families Journal of Family Nursing, November 1, 2004; 10(4): 485 - 505. [Abstract] [PDF]
|
|
|
|
|
|
M. R. Weihrauch and V. Diehl Artificial sweeteners--do they bear a carcinogenic risk? Ann. Onc., October 1, 2004; 15(10): 1460 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Rock, S. W. Flatt, C. A. Thomson, M. L. Stefanick, V. A. Newman, L. A. Jones, L. Natarajan, C. Ritenbaugh, K. A. Hollenbach, J. P. Pierce, et al. Effects of a High-Fiber, Low-Fat Diet Intervention on Serum Concentrations of Reproductive Steroid Hormones in Women With a History of Breast Cancer J. Clin. Oncol., June 15, 2004; 22(12): 2379 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Brenner and T. Hakulinen Are Patients Diagnosed With Breast Cancer Before Age 50 Years Ever Cured? J. Clin. Oncol., February 1, 2004; 22(3): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Ganz, G. A. Greendale, L. Petersen, B. Kahn, and J. E. Bower Breast Cancer in Younger Women: Reproductive and Late Health Effects of Treatment J. Clin. Oncol., November 15, 2003; 21(22): 4184 - 4193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ghafoor, A. Jemal, E. Ward, V. Cokkinides, R. Smith, and M. Thun Trends in Breast Cancer by Race and Ethnicity CA Cancer J Clin, November 1, 2003; 53(6): 342 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Silliman What Constitutes Optimal Care for Older Women With Breast Cancer? J. Clin. Oncol., October 1, 2003; 21(19): 3554 - 3556. [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Aziz Cancer Survivorship Research: Challenge and Opportunity J. Nutr., November 1, 2002; 132(11): 3494S - 3503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Bendre, D. Gaddy-Kurten, T. Mon-Foote, N. S. Akel, R. A. Skinner, R. W. Nicholas, and L. J. Suva Expression of Interleukin 8 and not Parathyroid Hormone-related Protein by Human Breast Cancer Cells Correlates with Bone Metastasis in Vivo Cancer Res., October 1, 2002; 62(19): 5571 - 5579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Katz-Brull, P. T. Lavin, and R. E. Lenkinski Clinical Utility of Proton Magnetic Resonance Spectroscopy in Characterizing Breast Lesions J Natl Cancer Inst, August 21, 2002; 94(16): 1197 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Rock and W. Demark-Wahnefried Nutrition and Survival After the Diagnosis of Breast Cancer: A Review of the Evidence J. Clin. Oncol., August 1, 2002; 20(15): 3302 - 3316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Kinsinger, R. Harris, S. H. Woolf, H. C. Sox, and K. N. Lohr Chemoprevention of Breast Cancer: A Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, July 2, 2002; 137(1): 59 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Cardoso, A. Di Leo, C. Lohrisch, C. Bernard, F. Ferreira, and M. J. Piccart Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? Ann. Onc., February 20, 2002; 13(2): 197 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Canto, W. F. Anderson, and O. Brawley Geographic Variation in Breast Cancer Mortality for White and Black Women: 1986-1995 CA Cancer J Clin, November 1, 2001; 51(6): 367 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Radina and J. M. Armer Post-Breast Cancer Lymphedema and the Family: A Qualitative Investigation of Families Coping With Chronic Illness Journal of Family Nursing, August 1, 2001; 7(3): 281 - 299. [Abstract] [PDF]
|
|
|
|
|
|
H. L. Howe, P. A. Wingo, M. J. Thun, L. A. G. Ries, H. M. Rosenberg, E. G. Feigal, and B. K. Edwards Annual Report to the Nation on the Status of Cancer (1973 Through 1998), Featuring Cancers With Recent Increasing Trends J Natl Cancer Inst, June 6, 2001; 93(11): 824 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. McDougal, M. Wormke, J. Calvin, and S. Safe Tamoxifen-induced Antitumorigenic/Antiestrogenic Action Synergized by a Selective Aryl Hydrocarbon Receptor Modulator Cancer Res., May 1, 2001; 61(10): 3902 - 3907. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Berlin Dot Size, Lead Time, Fallibility, and Impact on Survival: Continuing Controversies in Mammography Am. J. Roentgenol., May 1, 2001; 176(5): 1123 - 1130. [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Barton Screening mammography for women aged 40-49: Are we off the fence yet? Can. Med. Assoc. J., February 1, 2001; 164(4): 498 - 499. [Full Text] [PDF]
|
|
|
|
|
|
V. S. Erickson, M. L. Pearson, P. A. Ganz, J. Adams, and K. L. Kahn Arm Edema in Breast Cancer Patients J Natl Cancer Inst, January 17, 2001; 93(2): 96 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Basche and T. Byers Re: Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer J Natl Cancer Inst, January 3, 2001; 93(1): 64 - 65. [Full Text] [PDF]
|
|
|
|
|
|
R. McKean-Cowdin, H. S. Feigelson, R. K. Ross, M. C. Pike, and B. E. Henderson Declining Cancer Rates in the 1990s J. Clin. Oncol., June 11, 2000; 18(11): 2258 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Flaws, T. L. Bush, C. J. Newschaffer, K. C. Chu, R. E. Tarone, and O. W. Brawley Racial Differences in Breast Cancer Mortality Arch Fam Med, May 1, 2000; 9(5): 412 - 413. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Schrag, K. M. Kuntz, J. E. Garber, and J. C. Weeks Life Expectancy Gains From Cancer Prevention Strategies for Women With Breast Cancer and BRCA1 or BRCA2 Mutations JAMA, February 2, 2000; 283(5): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Chu, R. E. Tarone, and O. W. Brawley Breast Cancer Trends of Black Women Compared With White Women Arch Fam Med, November 1, 1999; 8(6): 521 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Barton, R. Harris, and S. W. Fletcher Does This Patient Have Breast Cancer?: The Screening Clinical Breast Examination: Should It Be Done? How? JAMA, October 6, 1999; 282(13): 1270 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Rizzieri, J. J. Vredenburgh, R. Jones, M. Ross, E. J. Shpall, A. Hussein, G. Broadwater, D. Berry, W. P. Petros, C. Gilbert, et al. Prognostic and Predictive Factors for Patients With Metastatic Breast Cancer Undergoing Aggressive Induction Therapy Followed by High-Dose Chemotherapy With Autologous Stem-Cell Support J. Clin. Oncol., October 1, 1999; 17(10): 3064 - 3074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Dopp and J. M Kolesar Risk of breast cancer associated with hormone replacement therapy Journal of Oncology Pharmacy Practice, September 1, 1999; 5(3): 109 - 116. [Abstract] [PDF]
|
|
|
|
 |
|
 P. A. Ganz The Quality of Life after Breast Cancer -- Solving the Problem of Lymphedema N. Engl. J. Med., February 4, 1999; 340(5): 383 - 385. [Full Text]
|
|
|
|
|
|
P. Rudolph, P. Alm, H.-J. Heidebrecht, H. Bolte, V. Ratjen, B. Baldetorp, M. Ferno, H. Olsson, and R. Parwaresch Immunologic Proliferation Marker Ki-S2 as Prognostic Indicator for Lymph Node-Negative Breast Cancer J Natl Cancer Inst, February 3, 1999; 91(3): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-A. Phillips, G. Glendon, and J. A. Knight Putting the Risk of Breast Cancer in Perspective N. Engl. J. Med., January 14, 1999; 340(2): 141 - 144. [Full Text]
|
|
|
|
|
|
G. N. Hortobagyi Treatment of Breast Cancer N. Engl. J. Med., October 1, 1998; 339(14): 974 - 984. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Buelow, A. H. Zimmer, M. J. Mellor, and R. Sax Mammography Screening for Older Minority Women Journal of Applied Gerontology, June 1, 1998; 17(2): 133 - 149. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Sourla, S. Luo, C. Labrie, A. Belanger, and F. Labrie Morphological Changes Induced by 6-Month Treatment of Intact and Ovariectomized Mice with Tamoxifen and the Pure Antiestrogen EM-800 Endocrinology, December 1, 1997; 138(12): 5605 - 5617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamauchi, N. Yamauchi, K. Ueki, T. Sugiyama, H. Waki, H. Miki, K. Tobe, S. Matsuda, T. Tsushima, T. Yamamoto, et al. Constitutive Tyrosine Phosphorylation of ErbB-2 via Jak2 by Autocrine Secretion of Prolactin in Human Breast Cancer J. Biol. Chem., October 20, 2000; 275(43): 33937 - 33944. [Abstract] [Full Text] [PDF]
|
|